SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012168-97-000057
Filing Date
1997-12-04
Accepted
1997-12-04 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A 44543
  Complete submission text file 0001012168-97-000057.txt   46511
Mailing Address 2525 DUPONT DR IRVINE CA 92715
Business Address 9393 TOWNE CENTER DR SAN DIEGO CA 92121 6195353900
ALLERGAN LIGAND RETINOID THERAPEUTICS INC (Subject) CIK: 0000934592 (see all company filings)

IRS No.: 330642614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45829 | Film No.: 97732438
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231